ID: ALA493586

Max Phase: Preclinical

Molecular Formula: C16H16O10

Molecular Weight: 368.29

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 4-Methylumbelliferone Glucuronide
Synonyms from Alternative Forms(1):

    Canonical SMILES:  O=C(O)[C@H]1O[C@@H](OCc2cc(=O)oc3cc(O)ccc23)[C@H](O)[C@@H](O)[C@@H]1O

    Standard InChI:  InChI=1S/C16H16O10/c17-7-1-2-8-6(3-10(18)25-9(8)4-7)5-24-16-13(21)11(19)12(20)14(26-16)15(22)23/h1-4,11-14,16-17,19-21H,5H2,(H,22,23)/t11-,12-,13+,14-,16+/m0/s1

    Standard InChI Key:  IHSDPYPXEDHVGB-JHZZJYKESA-N

    Associated Targets(Human)

    Canalicular multispecific organic anion transporter 1 1191 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    ATP-binding cassette sub-family G member 2 4927 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Multidrug resistance associated protein 78 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Solute carrier family 22 member 11 82 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Canalicular multispecific organic anion transporter 1 241 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Canalicular multispecific organic anion transporter 2 74 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 368.29Molecular Weight (Monoisotopic): 368.0743AlogP: -1.09#Rotatable Bonds: 4
    Polar Surface Area: 166.89Molecular Species: ACIDHBA: 9HBD: 5
    #RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 3.02CX Basic pKa: CX LogP: -0.95CX LogD: -4.60
    Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.42Np Likeness Score: 1.24

    References

    1. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P..  (2008)  Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).,  51  (11): [PMID:18457386] [10.1021/jm7015683]
    2. Hirohashi T, Suzuki H, Sugiyama Y..  (1999)  Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3).,  274  (1): [PMID:10329726] [10.1074/jbc.274.21.15181]
    3. Niinuma K, Takenaka O, Horie T, Kobayashi K, Kato Y, Suzuki H, Sugiyama Y..  (1997)  Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide.,  282  (1): [PMID:9262353]
    4. Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y..  (2003)  ABCG2 transports sulfated conjugates of steroids and xenobiotics.,  278  (1): [PMID:12682043] [10.1074/jbc.m212399200]
    5. Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, Endou H..  (2000)  Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta.,  275  (1): [PMID:10660625] [10.1074/jbc.275.6.4507]
    6. Akita H, Suzuki H, Hirohashi T, Takikawa H, Sugiyama Y..  (2002)  Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3.,  19  (1): [PMID:11837698] [10.1023/a:1013699130991]